Home
About Us
Inside Absci
Team
Our Values
Newsroom
Our Technology
Our Science
Publications
Case Studies
All
Pipeline
Partner With Us
Investors
Careers
Current Openings
Contact Us
Eli Lilly just placed a $40 million bet on the next injectable boom
Jul 02, 2026
Related
The Pre-clinical Science Behind ABS-201 for Endometriosis
Prolactin Receptor Blockade With ABS-201 Relieves Pain and Inflammation in a Homologous Transplant Mouse Model of Endometriosis
ABS-201 Case Study
View More
Share this post
Related Resources
The Pre-clinical Science Behind ABS-201 for Endometriosis
Read More
Prolactin Receptor Blockade With ABS-201 Relieves Pain and Inflammation in a Homologous Transplant Mouse Model of Endometriosis
Read More
ABS-201 Case Study
Read More
Load More
